Interplay between hepatitis B virus and TLR2-mediated innate immune responses: can restoration of TLR2 functions be a new therapeutic option?
David
D
Durantel
Fabien
F
Zoulim
D000818:Animals; D006515:Hepatitis B virus / Q000235:genetics*; D019694:Hepatitis B, Chronic / Q000378:metabolism*; D006801:Humans; D055666:Lipopeptides / Q000494:pharmacology*; D051195:Toll-Like Receptor 2 / Q000378:metabolism*
D055666:Lipopeptides; C508075:Pam(3)CSK(4) peptide; C560312:Pam2CSK4 lipopeptide; D051195:Toll-Like Receptor 2